Home/Bills/A 3116New York · 2025–2026 Legislative Session
Assembly BillIntroduced

A 3116: Requires health practitioners to discuss with patients the risks associated with certain pain medications before prescribing such medications; requires that for the first opioid analgesic prescription of a calendar year the prescribing physician shall counsel the patient on the risks of overdose.

New York · Assembly · 2025–2026 Legislative Session · last verified January 8, 2026

What A 3116 does, verified January 8, 2026

The bill aims to improve patient safety by requiring healthcare practitioners to discuss certain risks associated with pain medications before prescribing them. Practitioners must inform patients about the risks of addiction, overdose, and mixing opioids with other substances, as well as alternative treatments. For the first opioid analgesic prescription of the year, practitioners must counsel patients on the risks of overdose and inform them about the availability of opioid antagonists, such as naloxone. The bill also establishes guidelines for practitioners to follow in discussing these risks with patients. The law takes effect 120 days after it becomes a law, and allows for immediate implementation of necessary rules and regulations.

Bill journey
1IntroducedCurrent
2In CommitteePending
3First Chamber FloorPending
4Second ChamberPending
5GovernorPending
6ChapteredPending
Last action: referred to health (2026-01-07)Alert me
Quick answers about A 3116
What is the current status of A 3116?
As of January 8, 2026, A 3116 is recorded as "Introduced": it has been introduced and is waiting for its first committee hearing or floor vote. The last recorded action, on January 7, 2026, was "referred to health".
Did A 3116 pass?
Not yet. A 3116 has been introduced and has not passed either house.
Who wrote A 3116, and where is it now?
A 3116 was authored by Asm. Linda Rosenthal with 5 coauthors. Its committee of record is Assembly Health.
Author and sponsors
Full contact details, staff, and committees with Connect, $16/moUnlock
Coauthors
Marianne ButtenschonVacant MemberYudelka TapiaMaryJane ShimskyKeith Brown
Recent actions2 total · showing 2
Jan. 07, 2026referred to health
Jan. 23, 2025referred to health
Latest bill textIntroduced version, January 23, 2025 · 625 words
  
  STATE OF NEW YORK ________________________________________________________________________ 3116 2025-2026 Regular Sessions  IN ASSEMBLY January 23, 2025 ___________ Introduced by M. of A. ROSENTHAL, BUTTENSCHON, EPSTEIN, TAPIA, SHIMSKY, K. BROWN -- read once and referred to the Committee on Health AN ACT to amend the public health law, in relation to requiring health practitioners to discuss with patients the risks associated with certain pain medications before prescribing such medications; and in relation to opioid analgesic prescriptions The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. The public health law is amended by adding a new section 2 3309-c to read as follows: 3 § 3309-c. Practitioner and patient discussions; opioid prescriptions. 4 1. Prior to issuing the initial prescription of a Schedule II controlled 5 substance for the treatment of pain or any other opioid drug which is a 6 prescription drug for acute or chronic pain and again prior to issuing 7 the third prescription of the course of treatment, a practitioner shall 8 discuss with the patient, or the patient's parent or guardian if the 9 patient is under eighteen years of age and is not an emancipated minor, 10 the risks associated with the drugs being prescribed, including but not 11 limited to: 12 (a) the risks of addiction and overdose associated with opioid drugs 13 and the dangers of taking opioid drugs with alcohol, benzodiazepines and 14 other central nervous system depressants; 15 (b) the reasons why the prescription is necessary; 16 (c) alternative treatments that may be available; and 17 (d) the risks associated with the use of the drugs being prescribed, 18 specifically that opioids are highly addictive, even when taken as 19 prescribed, that there is a risk of developing a physical or psycholog- 20 ical dependence on the controlled substance, and that the risks of 21 taking more opioids than prescribed, or mixing sedatives, benzodiaze- 22 pines or alcohol with opioids, can result in fatal respiratory 23 depression. EXPLANATION--Matter in italics (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD01849-01-5 

 A. 3116 2 1 2. The department shall develop and make available to practitioners 2 guidelines for the discussion required by this section. 3 § 2. The public health law is amended by adding a new section 3309-d 4 to read as follows: 5 § 3309-d. Opioid analgesic prescription. 1. For the first opioid anal- 6 gesic prescription of a calendar year that is greater than a one week's 7 supply, the prescribing physician shall counsel the patient on the risks 8 of overdose, and inform the patient of the availability of an opioid 9 antagonist, including, but not limited to, naloxone. 10 2. For the purposes of this section, the following terms shall have 11 the following meanings: 12 (a) "Opioid analgesics" means the medicines buprenorphine, butorpha- 13 nol, codeine, hydrocodone, hydromorphone, levorphanol, meperidine, 14 methadone, morphine, nalbuphine, oxycodone, oxymorphone, pentazocine, 15 propoxyphene as well as their brand names, isomers and combinations. 16 (b) "Opioid antagonist" means an FDA-approved drug that, when adminis- 17 tered, negates or neutralizes in whole or in part the pharmacological 18 effects of an opioid in the body. The opioid antagonist is limited to 19 naloxone or other medications approved by the department for this 20 purpose. 21 § 3. This act shall take effect on the one hundred twentieth day after 22 it shall have become a law. Effective immediately, the addition, amend- 23 ment and/or repeal of any rule or regulation necessary for the implemen- 24 tation of this act on its effective date are authorized to be made and 25 completed on or before such effective date. 

Text of A 3116 as introduced, from the official record. Connect Plus keeps every version and highlights what changed.Compare versions
GovBuddy Demo

See how GovBuddy fits your team.

Share a few details and our team will follow up with a focused walkthrough.